Home > Analytics > NOVARTIS INDIA

NOVARTIS INDIA
Intrinsic Value | Fundamental Analysis

BOM : 500672     NSE : NOVARTIND    
LT :  
    Long Term Analysis
Fundamentals : Average
Valuation : Bad [Stock is Expensive]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Feb 20,2024
Price(EOD): ₹ 1,099.15
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Trading
MCap: ₹ 2,714.90 Cr
Value of ₹ 1 Lac invested in NOVARTIS INDIA
on Feb 20,2019 (price: ₹ 657.75)

₹ 1 L

₹ 1.67 L

1W : 20.9% 1M : 21.4% 1Y : 94.8%
COMMUNITY POLL
for NOVARTIS INDIA
Please provide your vote to see the results
NOVARTIS INDIA is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
Best 1M Momentum Small Cap Stocks
Industry Peers & Returns1W1M1Y
NOVARTIS INDIA 20.9% 21.4% 94.8%
ADANI ENTERPRISES 0.6% 10.7% 86.2%
REDINGTON (INDIA) 5.7% 18.4% 16.4%
MMTC 12.4% 26.7% 154.2%
OPTIEMUS INFRACOM 0.3% -0.1% 8.6%
MSTC 7.3% -0.7% 245.4%
SIRCA PAINTS INDIA 3% -7.8% 18%
POLO QUEEN INDUSTRIAL & FINTECH 0.3% -2.1% -4.4%
UNIPHOS ENTERPRISES 6.4% -7.8% -7.4%

FUNDAMENTAL ANALYSIS OF NOVARTIS INDIA

 
Fundamentals Score
[ Q(TTM): Dec2023, Y: Mar2023
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]


VALUATION OF NOVARTIS INDIA

 
Valuation Score
[As on : Feb 20,2024 ]

Ratio Standalone
P/E
P/B
P/S
28.41
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 95.53 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

3.5
P/B Calculated based on Book Value of Rs 775.70 Cr
[Latest Year - Mar2023 - Standalone Results ]

8.22
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Dec2023 - Standalone Results ]

Financial Ratios →

Insights 💡 There are potential 14% undervalued companies ! Discover More →

FAIR VALUE OF NOVARTIS INDIA

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
492%
256%
289%

Insights 💡 You can learn about various Valuation techniques to calculate Intrinsic Value
with our bestselling video course Value Investing - The Ultimate Guide
Take Me There →

SHARE PRICE MOMENTUM OF NOVARTIS INDIA


Insights 💡 NOVARTIND is one of the top 36% companies with bullish price momentum currently! Discover More →

NOVARTIS INDIA vs SENSEX


Insights 💡 You can learn about Basics of Stock Marketing Investing
with our bestselling video course Stock Marketing Investing Simplified
Take Me There →

DEBT OF NOVARTIS INDIA

Year Debt/Equity ratio
Standalone Consolidated
2023
2022
2021
Avg_3yrs
-
0
0
-
-
-
-
-
[Last Annual Data : Mar2023]
Financial Ratios →

PLEDGED PROMOTER SHARES OF NOVARTIS INDIA

Pledged Promoter Shares
0 %
As on : Dec2023

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad
Shareholding Pattern →

QTRLY RESULTS OF NOVARTIS INDIA

Standalone Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
7.34%
16.91%
27.38%
12.2%
5.45%
158.77%
190.1%
249.15%
QtrlyTrend
8
Latest Qtr: Dec2023
Quarterly Result Analysis →


NOVARTIS INDIA related INDICES

BSE Indices1W1M1Y
S&P BSE SMALL CAP 3.7% 4.4% 64.4%
S&P BSE MIDSMALLCAP 3.4% 5.4% 63.5%
S&P BSE ALLCAP 2.6% 4.5% 37.4%
S&P BSE HEALTHCARE 1.3% 9.8% 60.3%
No NSE index found

You may also like the below Video Courses


FAQ about NOVARTIS INDIA


Is NOVARTIS INDIA good for long term investment?

As on Feb 20,2024, the Fundamentals of NOVARTIS INDIA look Average and hence you may wait for the results to improve to invest for long term ! See Financial Performance of NOVARTIS INDIA . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is NOVARTIS INDIA UnderValued or OverValued?

As on Feb 20,2024, NOVARTIS INDIA is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of NOVARTIS INDIA ?

As on Feb 20,2024, the Intrinsic Value of NOVARTIS INDIA is Rs. 282.63 estimated based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 185.61
Fair Value [Median EV / Sales Model] : Rs. 308.93
Fair Value [Median Price / Sales Model] : Rs. 282.63
Estimated Median Fair Value of NOVARTIS INDIA : Rs. 282.63

The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.

Is NOVARTIS INDIA trading at a Premium or Discount?

As on Feb 20,2024, NOVARTIS INDIA is trading at a Premium of 289% based on the estimates of Median Intrinsic Value!